Promiscuous affairs of PKB/AKT isoforms in metabolism

The protein kinase B (PKB) family encompasses three isoforms; PKBα (AKT1), PKBβ (AKT2) and PKBγ (AKT3). PKBα and PKBβ but not PKBγ, are prominently expressed in classical insulin-sensitive tissues like liver, muscle and fat. Transgenic mice deficient for PKBα, PKBβ or PKBγ have been analysed to study the roles of PKB isoforms in metabolic regulation. Until recently, only loss of PKBβ was reported to result in metabolic disorders, especially insulin resistance, in humans and mice. However, a new study has shown that PKBα-deficient mice can show enhanced glucose tolerance accompanied by improved β-cell function and higher insulin sensitivity in adipocytes. These findings prompted us to review the relevant literature on the regulation of glucose metabolism by PKB isoforms in liver, skeletal muscle, adipocytes and pancreas.

[1]  D. Mears,et al.  An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. , 2010, Endocrinology.

[2]  G. Spinas,et al.  ER Stress in Adipocytes Inhibits Insulin Signaling, Represses Lipolysis, and Alters the Secretion of Adipokines Without Inhibiting Glucose Transport , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[3]  A. Toker,et al.  The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. , 2010, Molecular cell.

[4]  Hong Wu,et al.  The critical role of AKT2 in hepatic steatosis induced by PTEN loss. , 2010, The American journal of pathology.

[5]  B. Hemmings,et al.  Differential Effects of Protein Kinase B/Akt Isoforms on Glucose Homeostasis and Islet Mass , 2009, Molecular and Cellular Biology.

[6]  G. Shulman,et al.  Akt2 is required for hepatic lipid accumulation in models of insulin resistance. , 2009, Cell metabolism.

[7]  Qin-Hui Tuo,et al.  CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR‐320 IN INSULIN‐RESISTANT 3T3‐L1 ADIPOCYTES , 2009, Clinical and experimental pharmacology & physiology.

[8]  Wei⁃qin Zhao,et al.  Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. , 2009, Biochimica et biophysica acta.

[9]  T. McGraw,et al.  Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling , 2009, Proceedings of the National Academy of Sciences.

[10]  A. Gormand,et al.  Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[11]  J. Jensen,et al.  Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance , 2009, Archives of physiology and biochemistry.

[12]  Y. Terauchi,et al.  Crucial role of insulin receptor substrate‐2 in compensatory β‐cell hyperplasia in response to high fat diet–induced insulin resistance , 2008, Diabetes, obesity & metabolism.

[13]  David E James,et al.  IRS1-independent defects define major nodes of insulin resistance. , 2008, Cell metabolism.

[14]  K. Maedler.  Beta cells in type 2 diabetes – a crucial contribution to pathogenesis , 2008, Diabetes, obesity & metabolism.

[15]  B. Hemmings,et al.  PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. , 2008, Molecular cell.

[16]  L. Rachdi,et al.  Regulation of β‐cell mass and function by the Akt/protein kinase B signalling pathway , 2007, Diabetes, obesity & metabolism.

[17]  Spyro Mousses,et al.  A transforming mutation in the pleckstrin homology domain of AKT1 in cancer , 2007, Nature.

[18]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[19]  N. Hay,et al.  The two TORCs and Akt. , 2007, Developmental cell.

[20]  N. Fujii,et al.  Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[21]  Brian A. Hemmings,et al.  Only Akt1 Is Required for Proliferation, while Akt2 Promotes Cell Cycle Exit through p21 Binding , 2006, Molecular and Cellular Biology.

[22]  B. Hemmings,et al.  Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies , 2006, Molecular and Cellular Biology.

[23]  H. Koistinen,et al.  siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. , 2006, Cell metabolism.

[24]  C. Kahn,et al.  Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. , 2006, Cell metabolism.

[25]  Sunmin Park,et al.  Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function* , 2006, Journal of Biological Chemistry.

[26]  M. Niessen.  On the role of IRS2 in the regulation of functional β-cell mass , 2006 .

[27]  P. Shepherd,et al.  Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline. , 2005, Cellular signalling.

[28]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[29]  S. Akira,et al.  Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. , 2005, Journal of hepatology.

[30]  T. Ludwig,et al.  Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size , 2005, Molecular and Cellular Biology.

[31]  R. Lehmann,et al.  Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. , 2005, Experimental cell research.

[32]  James D. Johnson,et al.  Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. , 2004, The Journal of clinical investigation.

[33]  T. Mak,et al.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. , 2004, The Journal of clinical investigation.

[34]  C. Newgard.  Regulation of Glucose Metabolism in the Liver , 2004 .

[35]  B. Hemmings,et al.  Structure, regulation and function of PKB/AKT--a major therapeutic target. , 2004, Biochimica et biophysica acta.

[36]  R. Sherwin,et al.  Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Birnbaum,et al.  Isoform-specific Regulation of Insulin-dependent Glucose Uptake by Akt/Protein Kinase B* , 2003, Journal of Biological Chemistry.

[38]  T. Asano,et al.  Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. , 2003, Diabetes.

[39]  Sunmin Park,et al.  Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. , 2003, The Journal of clinical investigation.

[40]  C. Wrede,et al.  Decreasing IRS-2 expression in pancreatic β-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression , 2003, Molecular and Cellular Endocrinology.

[41]  L. Goodyear,et al.  Akt signaling in skeletal muscle: regulation by exercise and passive stretch. , 2003, American journal of physiology. Endocrinology and metabolism.

[42]  Brian A. Hemmings,et al.  Protein Kinase Bα/Akt1 Regulates Placental Development and Fetal Growth* , 2003, Journal of Biological Chemistry.

[43]  L. Cantley,et al.  Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions* , 2003, Journal of Biological Chemistry.

[44]  J. Stock,et al.  Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. , 2003, The Journal of clinical investigation.

[45]  Q. Boese,et al.  Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Dohm,et al.  Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. , 2003, Diabetes.

[47]  C. Wrede,et al.  Protein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic β-Cells (INS-1)* , 2002, The Journal of Biological Chemistry.

[48]  B. Hemmings,et al.  PKB Binding Proteins Getting in on the Akt , 2002, Cell.

[49]  L. Goodyear,et al.  Contraction Regulation of Akt in Rat Skeletal Muscle* , 2002, The Journal of Biological Chemistry.

[50]  M. Permutt,et al.  Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia , 2001 .

[51]  B. Hemmings,et al.  Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.

[52]  M. Birnbaum,et al.  Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.

[53]  I. Roninson,et al.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. , 2001, Genes & development.

[54]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[55]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[56]  S. O’Rahilly,et al.  Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle. , 2000, The Biochemical journal.

[57]  M. Czech,et al.  Stimulation of IRS-1-associated Phosphatidylinositol 3-Kinase and Akt/Protein Kinase B but Not Glucose Transport by β1-Integrin Signaling in Rat Adipocytes* , 1998, The Journal of Biological Chemistry.

[58]  D. Alessi,et al.  Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. , 1998, Diabetes.

[59]  M. Kasuga,et al.  Requirement for Activation of the Serine-Threonine Kinase Akt (Protein Kinase B) in Insulin Stimulation of Protein Synthesis but Not of Glucose Transport , 1998, Molecular and Cellular Biology.

[60]  M. Birnbaum,et al.  Insulin Increases the Association of Akt-2 with Glut4-containing Vesicles* , 1998, The Journal of Biological Chemistry.

[61]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[62]  P. Roach,et al.  New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin , 1997, Diabetes.

[63]  B. Hemmings,et al.  Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[65]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[66]  J. Hartley,et al.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[67]  B. Hemmings,et al.  Role of PKB/Akt in Liver Diseases , 2010 .

[68]  C. Trautwein,et al.  Signaling Pathways in Liver Diseases , 2008 .

[69]  D. James,et al.  Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. , 2007, Molecular endocrinology.

[70]  Sunmin Park,et al.  Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. , 2006, The Journal of biological chemistry.

[71]  M. Niessen.  On the role of IRS2 in the regulation of functional beta-cell mass. , 2006, Archives of physiology and biochemistry.

[72]  R. Freeman.  Signaling Pathways in Liver Diseases , 2006 .

[73]  P. Shepherd.  Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. , 2005, Acta physiologica Scandinavica.

[74]  T. Ludwig,et al.  Role for Akt3/protein kinase Bgamma in attainment of normal brain size. , 2005, Molecular and cellular biology.

[75]  B. Hemmings,et al.  Protein kinase B alpha/Akt1 regulates placental development and fetal growth. , 2003, The Journal of biological chemistry.

[76]  K. Kaestner,et al.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). , 2001, Science.

[77]  E. Furth,et al.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. , 2001, Nature medicine.

[78]  M. Permutt,et al.  Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. , 2001, The Journal of clinical investigation.

[79]  J. Turinsky,et al.  Akt kinases and 2-deoxyglucose uptake in rat skeletal muscles in vivo: study with insulin and exercise. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.